132475-93-5

Basic information

• Product Name: 2-Isopropyl-5-nitroaniline
• Synonyms: 2-Isopropyl-5-nitroaniline;Fumarate Impurity 3
• CAS NO: 132475-93-5
• Molecular Formula: C₉H₁₂N₂O₂
• Molecular Weight: 180.20378
• Mol File: 132475-93-5.mol
• Article Data: 6

Chemical Properties

• Appearance: /
• Storage Temp.: Keep in dark place,Inert atmosphere,Room temperature
• CAS DataBase Reference: 2-Isopropyl-5-nitroaniline(CAS DataBase Reference)
• NIST Chemistry Reference: 2-Isopropyl-5-nitroaniline(132475-93-5)
• EPA Substance Registry System: 2-Isopropyl-5-nitroaniline(132475-93-5)

Safety Data

• Hazardous Substances Data: 132475-93-5(Hazardous Substances Data)

Usage

General Description

2-Isopropyl-5-nitroaniline is a chemical compound with the molecular formula C9H12N2O2. It is a yellow crystalline solid that is used in the manufacturing of dyes and pigments. 2-Isopropyl-5-nitroaniline is also known as Solvent Yellow 33 or Sudan Yellow. It has been associated with various health hazards, including skin and eye irritation, respiratory issues, and potential liver damage. 2-Isopropyl-5-nitroaniline is considered a hazardous substance and should be handled with caution in industrial and laboratory settings.

Upstream product

• 643-28-7 2-isopropylaniline 

Downstream Products

• 170230-13-4 5-nitro-2-i-propylphenol 
• 1817-47-6 4-nitrocumene 
• 1055233-64-1 C₃₆H₅₄N₄O₆ 
• 1055233-62-9 C₂₇H₃₆N₂O₅ 
• 1055233-54-9 NEt-3IP 
• 1055233-03-8 C₂₃H₂₈N₂O₅ 
• 1055233-61-8 C₂₄H₃₃IN₂O₃ 
• 1055233-10-7 C₂₅H₂₈N₂O₃ 
• 1041186-88-2 C₁₃H₂₁NO*ClH 
• 1055233-70-9 C₂₆H₃₀N₂O₃ 
• 1055233-11-8 C₂₁H₂₆N₂O₃ 
• 1055233-72-1 C₂₂H₂₈N₂O₃ 
• 1055233-40-3 C₂₆H₃₆N₂O₃ 
• 1041186-87-1 C₁₂H₁₉NO*ClH 

Relevant articles and documents

PROTEIN KINASE C INHIBITORS AND USES THEREOF

This disclosure concerns compounds which are useful as inhibitors of protein kinase C (PKC) and are thus useful for treating a variety of diseases and disorders that are mediated or sustained through the activity of PKC. This disclosure also relates to pharmaceutical compositions comprising these compounds, methods of using these compounds in the treatment of various diseases and disorders, processes for preparing these compounds and intermediates useful in these processes.

Synthesis of symmetric dinitro-functionalised troeger's base analogues

The synthesis of six new examples of 2,8-dinitro-substituted Troeger's base analogues are reported, together with the first examples of 1,7-, 3,9- and 4,10-dinitro Troeger's base analogues and the first example of a tetranitro Troeger's base compound. Several of these dinitro compounds lack substituents at the 2- and 8-positions and therefore provide further examples of Troeger's base analogues derived from anilines lacking a para substituent.

COMPOUNDS AND METHODS FOR THE TREATMENT OF VIRUSES AND CANCER

The present invention relates to compounds according to the formula I: Where Ra is H or an optionally OH-substituted C1-C3 alkyl; R1 is OR1, an optionally substituted C4-12 carbocyclic group which may be saturated or unsaturated (including aromatic) or an optionally substituted heterocyclic group; R1 is an optionally substituted C1-C14 hydrocarbyl group or an optionally substituted heterocyclic group;; R2 , R3 and R4 are each independently H, an optionally substituted C1-C4 alkyl group (preferably CH3, CH2CH3 or CF3), halogen (preferably F, Cl, Br), OR, CN, NO2, a C1-C6 thioether, a C1-C6 thioester group, an optionally substituted CO2R group, an optionally substituted COR group or an optionally substituted OCOR group (preferably R4 is H); R is H or an optionally substituted C1-C6 alkyl group; RHET is an optionally substituted heterocyclic group; and pharmaceutically acceptable salts, solvates or polymorphs thereof.